Synergistic effect of olaparib (AZD2281) with combination of cisplatin on PTEN-deficient lung cancer cell lines

被引:0
|
作者
Minami, Daisuke [1 ]
Takigawa, Nagio [2 ]
Takeda, Hiromasa [3 ]
Takata, Minoru [4 ]
Ichihara, Eiki [1 ]
Hisamoto, Akiko [1 ]
Hotta, Katsyuyuki [1 ]
Tabata, Masahiro [1 ]
Tanimoto, Mitsune [1 ]
Kiura, Katsuyuki [1 ]
机构
[1] Okayama Univ Hosp, Okayama, Japan
[2] Kawasaki Med Sch, Okayama, Japan
[3] Tottori Municipal Hosp, Tottori, Japan
[4] Kyoto Univ, Kyoto, Japan
关键词
D O I
10.1158/1538-7445.AM2012-4686
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4686
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Effect of vesnarinone in combination with anti-cancer drugs on lung cancer cell lines
    Fujita, M
    Tsuchida, T
    Higashino, K
    ANTI-CANCER DRUGS, 1999, 10 (01) : 119 - 127
  • [42] Phase IB study to evaluate the efficacy and tolerability of olaparib (AZD2281) plus gefitinib in patients with epidermal growth factor receptor (EGFR) mutation positive advanced non-small-cell lung cancer (NSCLC) patients (pts). (NCT=1513174/GECP-GOAL)
    Garcia Campelo, R.
    Felip, E.
    Massuti, T.
    Majem, M.
    Carcereny, E.
    Palmero, R.
    Molina, M. A.
    Gonzalez-Arenas, C.
    Sanchez-Ronco, M.
    Rosell, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S802 - S803
  • [43] Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines
    Ohsaki, Y
    Ishida, S
    Fujikane, T
    Kikuchi, K
    ONCOLOGY, 1996, 53 (04) : 327 - 333
  • [44] Open, phase II randomized trial of gefitinib alone versus olaparib (AZD2281) plus gefitinib in advanced non-small cell lung cancer (NSCLC) patients (P) with epidermal growth factor receptor (EGFR) mutations: Spanish Lung Cancer Group trial (NCT=1513174/GECP-GOAL)
    Massuti, Bartomeu
    Garcia Campelo, Rosario
    Rodriguez Abreu, Deivys
    Remon, Jordi
    Mejem, Margarita
    Galvez, Elisa
    Antonio Ortega, Jose
    Aparisi, Francisco
    Reguart, Noemi
    Angeles Sala, Maria
    Isla, Dolores
    Sanchez Ronco, Maria
    Verdu, Aria
    Angel Molina-Vila, Miguel
    Mayo-de las Casas, Clara
    Pereira, Eva
    Cajal, Rosana
    Gonzalez-Arenas, Maria Carmen
    Carcereny, Enric
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Combination of SAHA and adenovirus-TRAIL showed synergistic antitumor effect by increasing TRAIL expression in lung cancer cell lines
    Lee, Choon-Taek
    Kim, Dal Rae
    Park, Mi-Young
    Yoon, Ho-Il
    Lee, Jae Ho
    Kim, Yeon-Soo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S597 - S597
  • [46] Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines
    Abdul Satar, Nazilah
    Ismail, Mohd Nazri
    Yahaya, Badrul Hisham
    MOLECULES, 2021, 26 (04):
  • [47] Synergistic anticancer effect of combination of AZD6244 and BYL719 targeting KRAS mutant in non-small cell lung cancer
    Jho, Eun Hye
    Kang, Sin I.
    Bae, Yeon-Hee
    Park, Young Mee
    Sun, Jong-Mu
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER RESEARCH, 2014, 74 (19)
  • [48] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines (vol 42, pg 1263, 2013)
    Ibrahim, Toni
    Liverani, Chiara
    Mercatali, Laura
    Sacanna, Emanuele
    Zanoni, Michele
    Fabbri, Francesco
    Zoli, Wainer
    Amadori, Dino
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) : 1260 - 1260
  • [49] The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells
    Takigawa, N
    Takeyama, M
    Shibayama, T
    Tada, A
    Kawata, N
    Okada, C
    Aoe, K
    Kozuki, T
    Hotta, K
    Tabata, M
    Kiura, K
    Ueoka, H
    Tanimoto, M
    Takahashi, K
    ONCOLOGY REPORTS, 2006, 15 (04) : 837 - 842
  • [50] Synergistic Antitumor Effect of a Combination of Paclitaxel and Carboplatin with Nobiletin from Citrus depressa on Non-Small-Cell Lung Cancer Cell Lines
    Uesato, Shinichi
    Yamashita, Hirofumi
    Maeda, Ryu
    Hirata, Yoshiyuki
    Yamamoto, Maho
    Matsue, Saki
    Nagaoka, Yasuo
    Shibano, Makio
    Taniguchi, Masahiko
    Baba, Kimiye
    Ju-ichi, Motoharu
    PLANTA MEDICA, 2014, 80 (06) : 452 - 457